Ron Mathijssen studied medicine at the Erasmus University Rotterdam for which he received his MD degree in 2000. Two years later he defended his thesis (cum laude) entitled: ‘Irinotecan: from Clinical Pharmacokinetics to Pharmacogenetics’. Subsequently, he became Internist, Medical Oncologist, and Clinical Pharmacologist. He is closely collaborating with national and international groups, supervises several PhD students, and published over 120 peer reviewed papers. In addition, he teaches students, reviews papers for many journals, and is a member of the Dutch Cancer Society scientific counsel. Finally, he is chair of the Dutch Pharmacology Oncology Group; a national collaboration to individualize the dose of anti-cancer drugs. Since 2013, he is a professor in Individualized Oncological Pharmacotherapy at the Department of Medical Oncology, heading the division of Translational Pharmacology. His main research is focused on ‘tailored therapy’ of systemic anti-cancer agents like taxanes, tamoxifen, irinotecan, tyrosine kinase inhibitors, and phase I drugs.
ClemensLowik简历_ClemensLowik受邀参会演讲_活动家
活动家是第三方嘉宾邀约平台。可根据演讲议题、会议日期、活动预算等要求，为您提供该领域内专业嘉宾演讲邀约服务，专家学者嘉宾远程视频分享发言，祝福致辞视频拍摄，网红明星艺人VCR活动录制，代言邀约，企业家国际顾问咨询服务。您可准备好活动信息后，联系电话：18911802888（王老师）（工作日9时至18时，仅邀约嘉宾出席活动，其他需求勿扰）